| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.4% stake in NextGen Healthcare Inc. |
| 10/06/2023 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 09/26/2023 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 08/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Eligible Award Recipients. Employees, Directors and Consultants are eligible to receive Awards. Available Awards. The Plan provides for the grant of the following types of Awards: Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights Restricted Stock Awards, Restricted Stock Unit Awards, Performance Stock Awards, Performance Cash Awards, and Other Stock Awards. Purpose. The Plan, through the granting of Awards, is intended to help the Company secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and provide a means by which the eligible recipients may benefit from increases in value of the Common Stock. 2. Administration. Administration by Board. The..." |
|
| 07/24/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
8-K
| Quarterly results |
| 06/16/2023 |
SC 13G
| Three Prong Investments, LLC reports a 15% stake in NextGen Healthcare, Inc. |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 02/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/27/2023 |
SC 13G/A
| BlackRock Inc. reports a 14.3% stake in NEXTGEN HEALTHCARE INC |
| 01/24/2023 |
8-K
| Quarterly results |
| 01/23/2023 |
SC 13G/A
| BlackRock Inc. reports a 14.4% stake in NEXTGEN HEALTHCARE INC |
| 12/05/2022 |
8-K
| Quarterly results |
| 11/01/2022 |
8-K
| Quarterly results |
| 10/25/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/25/2022 |
8-K
| Quarterly results |
| 08/18/2022 |
8-K
| Quarterly results |
| 08/05/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/26/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/26/2022 |
8-K
| Quarterly results |
| 07/14/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 05/20/2022 |
8-K
| Quarterly results |
| 05/17/2022 |
10-K
| Annual Report for the period ended March 31, 2022 |
| 05/17/2022 |
8-K
| Quarterly results |
| 05/02/2022 |
8-K
| Quarterly results |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.5% stake in NextGen Healthcare Inc. |
| 01/27/2022 |
SC 13G/A
| BlackRock Inc. reports a 14.5% stake in NEXTGEN HEALTHCARE INC |
| 01/25/2022 |
10-Q
| Quarterly Report for the period ended December 31, 2021 |
| 01/25/2022 |
8-K
| Quarterly results |
| 01/25/2022 |
SC 13G/A
| BlackRock Inc. reports a 14.5% stake in NEXTGEN HEALTHCARE INC |
| 01/10/2022 |
SC 13G/A
| BROWN CAPITAL MANAGEMENT LLC reports a 2.2% stake in Nextgen Healthcare, Inc. |
| 11/10/2021 |
SC 13G/A
| BROWN CAPITAL MANAGEMENT LLC reports a 7.5% stake in Nextgen Healthcare, Inc. |
| 10/29/2021 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
|